An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Approved Blood Products

NovoSevenRT

STN: BL 103665
Proper Name: Coagulation Factor VIIa (Recombinant)
Tradename: NovoSevenRT
Manufacturer: Novo Nordisk Inc, License #1261

Treatment of bleeding episodes and peri-operative management in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and Glanzmann’s thrombasthenia with refractoriness to platelet transfusions, with or without antibodies to platelets.
Treatment of bleeding episodes and peri-operative management in adults with acquired hemophilia.

Product Information

Package Insert - NovoSevenRT

Supporting Documents

Supporting Documents older than three years - NovoSevenRT

Top